Allison's work has had a profound impact on cancer treatment, leading to the development of a new class of drugs known as immune checkpoint inhibitors. These drugs have been approved for the treatment of various types of cancer, including melanoma, lung cancer, kidney cancer, and more. The success of these therapies has opened new avenues for cancer treatment and has provided hope to patients who previously had limited options.
